The 27-day notice: how a compounding wind-down works in Spain
The document is four pages. Three of them are about dates.
Shortage listings
Page 2 of 13 of this archive, newest first.
Side effects, cost, supply, target: four reasons with four trajectories
Why the reason for stopping changes what happens afterwards.
The supply gap as a clinical event
Why the reason for stopping changes what happens afterwards.
The 7-day notice: how a compounding wind-down works in Nigeria
The document is four pages. Three of them are about dates.
Why people actually stop, in the order they actually stop
A supply interruption is a discontinuation with no notice, no taper and no plan. That is a distinct clinical situation.
The 10-day notice: how a compounding wind-down works in Ireland
The document is four pages. Three of them are about dates.
The 8-day notice: how a compounding wind-down works in the United Arab Emirates
The document is four pages. Three of them are about dates.
The supply gap as a clinical event
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
The 13-day notice: how a compounding wind-down works in South Africa
The document is four pages. Three of them are about dates.
A shortage listing ends. 17 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 8 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The 28-day notice: how a compounding wind-down works in Argentina
The document is four pages. Three of them are about dates.
A shortage listing ends. 16 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 3 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Continued treatment against continued placebo: the comparison that settled it
The regain trajectories, arm by arm, with the estimands named.
The supply gap as a clinical event
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
The 30-day notice: how a compounding wind-down works in India
The document is four pages. Three of them are about dates.
What happens when the drug is taken away: three randomised answers
What was withdrawn, from whom, after how long, and what was measured afterwards.
The lowest effective dose is a real concept with almost no data behind it
A survey of the maintenance evidence, which is shorter than the survey of the withdrawal evidence.
The 16-day notice: how a compounding wind-down works in France
The document is four pages. Three of them are about dates.